Aerovanc Development

CFFT Has Provided $1.7m Research Award to US-based Savara Pharmaceuticals
Oct 21, 2013
Cystic Fibrosis Foundation Therapeutics (CFFT), an affiliate of the CF Foundation, has provided $1.7m research award to US-based Savara Pharmaceuticals for advancing the development of AeroVanc (vancomycin hydrochloride inhalation powder). ...

Tags: Savara Pharmaceuticals, Aerovanc Development